These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 35190921)

  • 1. COVID-19 and cancer: start the resolution!
    Barksdale C; Kipper FC; Tripathy S; Subbian S; Serhan CN; Panigrahy D
    Cancer Metastasis Rev; 2022 Mar; 41(1):1-15. PubMed ID: 35190921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?
    Panigrahy D; Gilligan MM; Huang S; Gartung A; Cortés-Puch I; Sime PJ; Phipps RP; Serhan CN; Hammock BD
    Cancer Metastasis Rev; 2020 Jun; 39(2):337-340. PubMed ID: 32385712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possibility of averting cytokine storm in SARS-COV 2 patients using specialized pro-resolving lipid mediators.
    Yasmeen N; Selvaraj H; Lakhawat SS; Datta M; Sharma PK; Jain A; Khanna R; Srinivasan J; Kumar V
    Biochem Pharmacol; 2023 Mar; 209():115437. PubMed ID: 36731803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of specialized pro-resolving lipid mediators and their receptors in virus infection: a promising therapeutic strategy for SARS-CoV-2 cytokine storm.
    Lee CH
    Arch Pharm Res; 2021 Jan; 44(1):84-98. PubMed ID: 33398691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity-Driven Deficiencies of Specialized Pro-resolving Mediators May Drive Adverse Outcomes During SARS-CoV-2 Infection.
    Pal A; Gowdy KM; Oestreich KJ; Beck M; Shaikh SR
    Front Immunol; 2020; 11():1997. PubMed ID: 32983141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specialized pro-resolving lipid mediators regulate inflammatory macrophages: A paradigm shift from antibiotics to immunotherapy for mitigating COVID-19 pandemic.
    Kumar V; Yasmeen N; Chaudhary AA; Alawam AS; Al-Zharani M; Suliman Basher N; Harikrishnan S; Goud MD; Pandey A; Lakhawat SS; Sharma PK
    Front Mol Biosci; 2023; 10():1104577. PubMed ID: 36825200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The function of specialized pro-resolving endogenous lipid mediators, vitamins, and other micronutrients in the control of the inflammatory processes: Possible role in patients with SARS-CoV-2 related infection.
    Gallo CG; Fiorino S; Posabella G; Antonacci D; Tropeano A; Pausini E; Pausini C; Guarniero T; Hong W; Giampieri E; Corazza I; Loiacono R; Loggi E; de Biase D; Zippi M; Lari F; Zancanaro M
    Prostaglandins Other Lipid Mediat; 2022 Apr; 159():106619. PubMed ID: 35032665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specialized pro-resolving mediator network: an update on production and actions.
    Chiang N; Serhan CN
    Essays Biochem; 2020 Sep; 64(3):443-462. PubMed ID: 32885825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parenteral fish oil: An adjuvant pharmacotherapy for coronavirus disease 2019?
    Torrinhas RS; Calder PC; Lemos GO; Waitzberg DL
    Nutrition; 2021 Jan; 81():110900. PubMed ID: 32738510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specialized Pro-Resolving Mediators as Potential Regulators of Inflammatory Macrophage Responses in COVID-19.
    Balta MG; Papathanasiou E; Christopoulos PF
    Front Immunol; 2021; 12():632238. PubMed ID: 33717168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
    J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pentoxifylline and Oxypurinol: Potential Drugs to Prevent the
    López-Iranzo FJ; López-Rodas AM; Franco L; López-Rodas G
    Curr Pharm Des; 2020; 26(35):4515-4521. PubMed ID: 32787748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weathering the Storm: Harnessing the Resolution of Inflammation to Limit COVID-19 Pathogenesis.
    Silberberg E; Filep JG; Ariel A
    Front Immunol; 2022; 13():863449. PubMed ID: 35615359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
    Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Before the "cytokine storm": Boosting efferocytosis as an effective strategy against SARS-CoV-2 infection and associated complications.
    Dutta S; Mukherjee A; Nongthomba U
    Cytokine Growth Factor Rev; 2022 Feb; 63():108-118. PubMed ID: 35039221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.
    Kulanthaivel S; Kaliberdenko VB; Balasundaram K; Shterenshis MV; Scarpellini E; Abenavoli L
    Rev Recent Clin Trials; 2021; 16(2):138-145. PubMed ID: 32940187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine Storm and Failed Resolution in COVID-19: Taking a Cue from Multiple Sclerosis.
    Zahoor I; Li Y; Rattan R; Giri S
    Adv Exp Med Biol; 2021; 1352():211-222. PubMed ID: 35132603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration.
    Chen R; Lan Z; Ye J; Pang L; Liu Y; Wu W; Qin X; Guo Y; Zhang P
    Front Immunol; 2021; 12():589095. PubMed ID: 33995341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine storm syndrome in SARS-CoV-2: a review.
    Wahid B; Rani N; Idrees M
    Z Naturforsch C J Biosci; 2022 Jan; 77(1-2):65-69. PubMed ID: 34428364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resolution of inflammation: An organizing principle in biology and medicine.
    Panigrahy D; Gilligan MM; Serhan CN; Kashfi K
    Pharmacol Ther; 2021 Nov; 227():107879. PubMed ID: 33915177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.